METTL14 and neoplasm: Mediated by YTDHF2, METTL3/METTL14 knockdown stabilizes STAT1 and Irf1 mRNAs, and promotes IFN‐γ‐STAT1‐Irf1 signaling, which in turn sensitizes tumor cells to PD‐1 inhibition.